Zoetis announced Feb. 5 the launch of Carysta HVC (high-volume chemistry), a stand-alone chemistry diagnostic instrument designed to bring reference-lab quality testing to high-volume veterinary practices.

Zoetis said Carysta HVC offers a menu of 37 routine and specialty parameters -- available as singly selected tests or fully customizable panels -- all on one system. The instrument offers veterinarians greater operational flexibility than current instrument solutions while improving quality, productivity and reducing clinic costs of testing. Availability is expected in March 2018. Carysta HVC is specifically designed for veterinary practices conducting the highest volume of diagnostic tests, as such practices would benefit from the increased throughput of the instrument, the announcement explained.

“Zoetis is bringing to market an innovative, high-quality, diagnostic instrument specifically designed for veterinary use,” said Dr. Richard E. Goldstein, executive director and chief medical officer of U.S. Diagnostics.

Carysta HVC is based on liquid reagent technology ideally suited for veterinary clinics, reference laboratories and shelters that need greater throughput and test selection flexibility, the company said.

The easy-to-use system runs multiple patient samples simultaneously with minimal sample volumes, enabling high-volume veterinary clinics to practice cost-effective medicine based on patient needs and allowing customized test selection based on veterinary requirements. It also gives veterinarians the ability to add urgent samples with no work flow interruption.

Carysta HVC will be distributed through an exclusive partnership with DiaSys Diagnostic Systems USA LLC.

“The HVC instrument will assist high-volume veterinary clinics and regional laboratories to gain improved productivity at a lower cost, while obtaining reference laboratory-quality results. The instrument’s innovative design enables our veterinary customers to achieve greater throughput and high-level test performance,” said Lisa Lee, vice president, U.S. Diagnostics and Business Solutions at Zoetis.

Carysta HVC is part of a growing commitment to veterinary diagnostics, enabling Zoetis to support veterinarians in their ability to predict, detect, prevent and treat disease. Customers can learn more about Carysta HVC at www.carysta.com.

Zoetis is the leading animal health company dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services.